Global Nucleic Acid-based Therapeutics Market Research Report 2024(Status and Outlook)

Global Nucleic Acid-based Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

The Global Nucleic Acid-based Therapeutics Market Size was estimated at USD 561.97 million in 2023 and is projected to reach USD 706.98 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.

This report provides a deep insight into the global Nucleic Acid-based Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nucleic Acid-based Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nucleic Acid-based Therapeutics market in any manner.

Global Nucleic Acid-based Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Wave Life Sciences

Imugene

Caperna

Phylogica

Protagonist Therapeutics

Benitec Biopharma

EGEN

BioMedica

Transgene

Copernicus Therapeutics

Market Segmentation (by Type)

Anti-Sense And Anti-Gene

Short Inhibitory Sequences

Gene Transfer Therapy

Nucleoside Analogs

Ribozymes

Aptamers

Market Segmentation (by Application)

Hospitals

Academic & Research Institutes

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Nucleic Acid-based Therapeutics Market

Overview of the regional outlook of the Nucleic Acid-based Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid-based Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid-based Therapeutics
1.2 Key Market Segments
1.2.1 Nucleic Acid-based Therapeutics Segment by Type
1.2.2 Nucleic Acid-based Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid-based Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid-based Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nucleic Acid-based Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid-based Therapeutics Market Competitive Landscape
3.1 Global Nucleic Acid-based Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid-based Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nucleic Acid-based Therapeutics Sales Sites, Area Served, Product Type
3.6 Nucleic Acid-based Therapeutics Market Competitive Situation and Trends
3.6.1 Nucleic Acid-based Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid-based Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid-based Therapeutics Industry Chain Analysis
4.1 Nucleic Acid-based Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid-based Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid-based Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Nucleic Acid-based Therapeutics Price by Type (2019-2024)
7 Nucleic Acid-based Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid-based Therapeutics Market Sales by Application (2019-2024)
7.3 Global Nucleic Acid-based Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Nucleic Acid-based Therapeutics Sales Growth Rate by Application (2019-2024)
8 Nucleic Acid-based Therapeutics Market Segmentation by Region
8.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.1 Global Nucleic Acid-based Therapeutics Sales by Region
8.1.2 Global Nucleic Acid-based Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid-based Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid-based Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid-based Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid-based Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid-based Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Wave Life Sciences
9.1.1 Wave Life Sciences Nucleic Acid-based Therapeutics Basic Information
9.1.2 Wave Life Sciences Nucleic Acid-based Therapeutics Product Overview
9.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Product Market Performance
9.1.4 Wave Life Sciences Business Overview
9.1.5 Wave Life Sciences Nucleic Acid-based Therapeutics SWOT Analysis
9.1.6 Wave Life Sciences Recent Developments
9.2 Imugene
9.2.1 Imugene Nucleic Acid-based Therapeutics Basic Information
9.2.2 Imugene Nucleic Acid-based Therapeutics Product Overview
9.2.3 Imugene Nucleic Acid-based Therapeutics Product Market Performance
9.2.4 Imugene Business Overview
9.2.5 Imugene Nucleic Acid-based Therapeutics SWOT Analysis
9.2.6 Imugene Recent Developments
9.3 Caperna
9.3.1 Caperna Nucleic Acid-based Therapeutics Basic Information
9.3.2 Caperna Nucleic Acid-based Therapeutics Product Overview
9.3.3 Caperna Nucleic Acid-based Therapeutics Product Market Performance
9.3.4 Caperna Nucleic Acid-based Therapeutics SWOT Analysis
9.3.5 Caperna Business Overview
9.3.6 Caperna Recent Developments
9.4 Phylogica
9.4.1 Phylogica Nucleic Acid-based Therapeutics Basic Information
9.4.2 Phylogica Nucleic Acid-based Therapeutics Product Overview
9.4.3 Phylogica Nucleic Acid-based Therapeutics Product Market Performance
9.4.4 Phylogica Business Overview
9.4.5 Phylogica Recent Developments
9.5 Protagonist Therapeutics
9.5.1 Protagonist Therapeutics Nucleic Acid-based Therapeutics Basic Information
9.5.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Overview
9.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
9.5.4 Protagonist Therapeutics Business Overview
9.5.5 Protagonist Therapeutics Recent Developments
9.6 Benitec Biopharma
9.6.1 Benitec Biopharma Nucleic Acid-based Therapeutics Basic Information
9.6.2 Benitec Biopharma Nucleic Acid-based Therapeutics Product Overview
9.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Product Market Performance
9.6.4 Benitec Biopharma Business Overview
9.6.5 Benitec Biopharma Recent Developments
9.7 EGEN
9.7.1 EGEN Nucleic Acid-based Therapeutics Basic Information
9.7.2 EGEN Nucleic Acid-based Therapeutics Product Overview
9.7.3 EGEN Nucleic Acid-based Therapeutics Product Market Performance
9.7.4 EGEN Business Overview
9.7.5 EGEN Recent Developments
9.8 BioMedica
9.8.1 BioMedica Nucleic Acid-based Therapeutics Basic Information
9.8.2 BioMedica Nucleic Acid-based Therapeutics Product Overview
9.8.3 BioMedica Nucleic Acid-based Therapeutics Product Market Performance
9.8.4 BioMedica Business Overview
9.8.5 BioMedica Recent Developments
9.9 Transgene
9.9.1 Transgene Nucleic Acid-based Therapeutics Basic Information
9.9.2 Transgene Nucleic Acid-based Therapeutics Product Overview
9.9.3 Transgene Nucleic Acid-based Therapeutics Product Market Performance
9.9.4 Transgene Business Overview
9.9.5 Transgene Recent Developments
9.10 Copernicus Therapeutics
9.10.1 Copernicus Therapeutics Nucleic Acid-based Therapeutics Basic Information
9.10.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Overview
9.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product Market Performance
9.10.4 Copernicus Therapeutics Business Overview
9.10.5 Copernicus Therapeutics Recent Developments
10 Nucleic Acid-based Therapeutics Market Forecast by Region
10.1 Global Nucleic Acid-based Therapeutics Market Size Forecast
10.2 Global Nucleic Acid-based Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nucleic Acid-based Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Nucleic Acid-based Therapeutics Market Size Forecast by Region
10.2.4 South America Nucleic Acid-based Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid-based Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nucleic Acid-based Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nucleic Acid-based Therapeutics by Type (2025-2030)
11.1.2 Global Nucleic Acid-based Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nucleic Acid-based Therapeutics by Type (2025-2030)
11.2 Global Nucleic Acid-based Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Nucleic Acid-based Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Nucleic Acid-based Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings